Clinical Trial Update: Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating nitric oxide–mediated cardioprotection during cardiac surgery with cardiopulmonary bypass; completed phase 1 and phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Bypass Grafting
• Coronary Artery Disease
• Reperfusion Injury Myocardial

Snippet

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences | Conditions: Coronary Artery Disease, Coronary Artery Bypass | Phase 1, Phase 2 | Status: COMPLETED